万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生2>>免疫学

Clinical & Experimental Immunology(或:Clinical and Experimental Immunology)《临床与实验免疫学》 (官网投稿)

简介
  • 期刊简称CLIN EXP IMMUNOL
  • 参考译名《临床与实验免疫学》
  • 核心类别 SCIE(2023版), 目次收录(知网),外文期刊,
  • IF影响因子
  • 自引率1.30%
  • 主要研究方向医学-IMMUNOLOGY免疫学

主要研究方向:

等待设置主要研究方向
医学-IMMUNOLOGY免疫学

Clinical & Experimental Immunology《临床与实验免疫学》(月刊). Clinical & Experimental Immunology (CEI) is an authoritative, international and well-respected ...[显示全部]
征稿信息

万维提示:

1、投稿方式:在线投稿。

2、期刊网址:https://academic.oup.com/cei

3、投稿网址:https://mc.manuscriptcentral.com/cei

4、官网邮箱:journals@immunology.org(编辑部)

5、官网电话:+44 (0) 7392 935249(编辑部)

6、期刊刊期:月刊,一年出版12期。

2022117日星期一

                              

 

投稿须知【官网信息】

 

Instructions to Authors

About the Journal

Clinical & Experimental Immunology (CEI) is a peer-reviewed journal brought to you by the British Society for Immunology. CEI publishes 12 issues per year in four volumes, in print and in online formats. All articles accepted for publication will appear in both versions.

Please read these instructions carefully and follow them closely. The Editors may return manuscripts that do not follow these instructions.

Scope of the Journal

Clinical & Experimental Immunology is an authoritative international journal publishing high-quality papers in translational and clinical immunology that have the potential to transform our understanding of the immunopathology of human disease and/or change clinical practice. Clinical studies and basic immunology studies that inform clinical practice or understanding of disease mechanisms are also welcomed, as are studies in non-human model systems and reports on the physiological mechanisms of immunity as they relate to human disease.

Papers are published in the following areas of interest:

Adaptive immunity

Allergies and Hypersensitivity

Autoimmunity

Clinical and Human Immunology

Immune Recognition

Immune Regulation

Immune System Development

Immunodeficiency

Immunogenetics

Immunotherapy and Vaccines

Infectious Disease

Inflammation

Innate Immunity

Mucosal Immunology

Neuroimmunology

Novel Methodologies

Transplantation

Tumour Immunology

In general, the following studies are not published in CEI, unless they represent major breakthroughs in the field:

New Reagents

Research Techniques

Clinical Case Reports

CEI also publishes review articles on subjects of topical interest to immunologists and clinicians. While many of the reviews published are commissioned by the editors, CEI welcomes unsolicited reviews.

Contents

About the Journal

Editorial Policies

Submission

Third-Party Permissions

Manuscript Preparation: Format, Structure, and Style

Licence to Publish and Open Access Options

Editorial Policies

Details of Oxford University Press’s editorial policies are available.

Peer Review

This journal uses single blind peer review. Full details about the peer review process are available.

Data Policy

Availability of Data and Materials

Where ethically feasible, Clinical & Experimental Immunology strongly encourages authors to make all data and software code on which the conclusions of the paper rely available to readers. Authors are required to include a Data Availability Statement in their article.

We suggest that data be presented in the main manuscript or additional supporting files, or deposited in a public repository whenever possible. Information on general repositories for all data types, and a list of recommended repositories by subject area, is available here.

Data Availability Statement

The inclusion of a Data Availability Statement is a requirement for articles published in Clinical & Experimental Immunology. Data Availability Statements provide a standardised format for readers to understand the availability of data underlying the research results described in the article. The statement may refer to original data generated in the course of the study or to third-party data analysed in the article. The statement should describe and provide means of access, where possible, by linking to the data or providing the required unique identifier.

The Data Availability Statement should be included in the endmatter of your article under the heading ‘Data availability’.

More information and example Data Availability Statements can be found here.

……

更多详情:

https://academic.oup.com/cei/pages/general-instructions


  • 万维QQ投稿交流群    招募志愿者

    版权所有 Copyright@2009-2015豫ICP证合字09037080号

     纯自助论文投稿平台    E-mail:eshukan@163.com


投稿问答最小化  关闭